Hôpital Emile Muller

Mulhouse, Grand Est 8051

2 studies enrolling now · 4 studies all time

What they study most

Acute Myeloid Leukemia, Adjuvant, Chronic Myelomonocytic Leukemia, EGFR, Early Stage Lung Cancer, Exon 20, Lung Cancer, Myelodysplastic Syndromes, Myelofibrosis, NSCLC, Stage IB-IIIA, Patients With Non-Small Cell Lung Cancer, Post-surgical

Studies at this site

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now
• A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) — Enrolling by invitation
• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling
• Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis — Running, not enrolling